share_log

Xeris Pharmaceuticals Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $25.31M Miss $25.53M Estimate

Xeris Pharmaceuticals Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $25.31M Miss $25.53M Estimate

Xeris PharmPharmticals第二季度每股收益为0.19美元,高于上年同期的0.41美元,销售额为2531万美元,错过了2553万美元的预期
Benzinga Real-time News ·  2022/08/10 07:10

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.19) per share. This is a 53.66 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $25.31 million which missed the analyst consensus estimate of $25.53 million by 0.88 percent. This is a 186.43 percent increase over sales of $8.84 million the same period last year.

纳斯达克公司(Xeris PharmPharmticals)公布季度每股亏损0.19美元。这比去年同期每股亏损0.41美元增加了53.66%。该公司公布的季度销售额为2,531万美元,低于分析师一致预期的2,553万美元,降幅为0.88%。这比去年同期884万美元的销售额增长了186.43个百分点。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发